Monarch Capital Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.39M | Buy |
37,388
+330
| +0.9% | +$30.3K | 0.83% | 40 |
|
|
2025
Q4 | $3.34M | Buy |
37,058
+995
| +3% | +$94.3K | 0.82% | 38 |
|
|
2025
Q3 | $3.56M | Buy |
36,063
+1,035
| +3% | +$103K | 0.87% | 38 |
|
|
2025
Q2 | $3.2M | Buy |
35,028
+695
| +2% | +$67.2K | 0.86% | 37 |
|
|
2025
Q1 | $3.89M | Sell |
34,333
-238
| -0.7% | -$25.5K | 1.08% | 34 |
|
|
2024
Q4 | $3.66M | Sell |
34,571
-100
| -0.3% | -$10.7K | 1% | 35 |
|
|
2024
Q3 | $3.75M | Buy |
34,671
+68
| +0.2% | +$7.42K | 1.01% | 35 |
|
|
2024
Q2 | $3.76M | Sell |
34,603
-33
| -0.1% | -$3.89K | 1.11% | 32 |
|
|
2024
Q1 | $4.58M | Sell |
34,636
-33
| -0.1% | -$4.12K | 1.29% | 30 |
|
|
2023
Q4 | $4.23M | Sell |
34,669
-663
| -2% | -$74K | 1.28% | 29 |
|
|
2023
Q3 | $3.97M | Sell |
35,332
-195
| -0.5% | -$24.8K | 1.28% | 29 |
|
|
2023
Q2 | $5.18M | Sell |
35,527
-783
| -2% | -$106K | 1.57% | 23 |
|
|
2023
Q1 | $4.7M | Sell |
36,310
-238
| -0.7% | -$29.9K | 1.44% | 25 |
|
|
2022
Q4 | $4.67M | Sell |
36,548
-2,117
| -5% | -$246K | 1.43% | 28 |
|
|
2022
Q3 | $4.05M | Sell |
38,665
-1,659
| -4% | -$182K | 1.32% | 31 |
|
|
2022
Q2 | $4.24M | Buy |
40,324
+475
| +1% | +$56.4K | 1.26% | 32 |
|
|
2022
Q1 | $5.1M | Sell |
39,849
-612
| -2% | -$73.8K | 1.35% | 31 |
|
|
2021
Q4 | $4.99M | Buy |
40,461
+149
| +0.4% | +$19.5K | 1.28% | 31 |
|
|
2021
Q3 | $5.73M | Buy |
40,312
+341
| +0.9% | +$50.2K | 1.59% | 25 |
|
|
2021
Q2 | $6.24M | Hold |
39,971
| – | – | 1.78% | 21 |
|
|
2021
Q1 | $6.21M | Sell |
39,971
-2,755
| -6% | -$427K | 1.84% | 22 |
|
|
2020
Q4 | $6.39M | Sell |
42,726
-1,475
| -3% | -$208K | 2.01% | 20 |
|
|
2020
Q3 | $5.84M | Sell |
44,201
-132
| -0.3% | -$17.2K | 2.03% | 19 |
|
|
2020
Q2 | $5.14M | Sell |
44,333
-2,538
| -5% | -$292K | 1.88% | 23 |
|
|
2020
Q1 | $4.6M | Buy |
46,871
+5,140
| +12% | +$674K | 1.88% | 23 |
|
|
2019
Q4 | $6.06M | Buy |
41,731
+122
| +0.3% | +$16.8K | 1.98% | 21 |
|
|
2019
Q3 | $5.54M | Sell |
41,609
-41
| -0.1% | -$5.3K | 1.94% | 20 |
|
|
2019
Q2 | $4.76M | Buy |
41,650
+665
| +2% | +$77.9K | 1.7% | 24 |
|
|
2019
Q1 | $5.08M | Buy |
40,985
+575
| +1% | +$65.3K | 1.84% | 22 |
|
|
2018
Q4 | $4.07M | Buy |
40,410
+1,374
| +4% | +$155K | 1.65% | 26 |
|
|
2018
Q3 | $4.98M | Sell |
39,036
-330
| -0.8% | -$39.2K | 1.8% | 25 |
|
|
2018
Q2 | $4.26M | Buy |
39,366
+330
| +0.8% | +$35.9K | 1.63% | 27 |
|
|
2018
Q1 | $4.13M | Buy |
39,036
+1,038
| +3% | +$121K | 1.59% | 27 |
|
|
2017
Q4 | $4.45M | Sell |
37,998
-2,118
| -5% | -$240K | 1.66% | 26 |
|
|
2017
Q3 | $4.56M | Buy |
40,116
+654
| +2% | +$75.5K | 1.7% | 26 |
|
|
2017
Q2 | $4.92M | Buy |
39,462
+3,048
| +8% | +$361K | 1.86% | 23 |
|
|
2017
Q1 | $4.32M | Buy |
36,414
+376
| +1% | +$42.6K | 1.58% | 27 |
|
|
2016
Q4 | $3.61M | Buy |
36,038
+5,219
| +17% | +$559K | 1.35% | 31 |
|
|
2016
Q3 | $3.89M | Buy |
30,819
+26
| +0.1% | +$3.21K | 1.47% | 29 |
|
|
2016
Q2 | $3.6M | Hold |
30,793
| – | – | 1.34% | 31 |
|
|
2016
Q1 | $3.19M | Buy |
30,793
+2,209
| +8% | +$214K | 1.15% | 35 |
|
|
2015
Q4 | $2.85M | Sell |
28,584
-144
| -0.5% | -$14.1K | 1.09% | 34 |
|
|
2015
Q3 | $2.62M | Buy |
28,728
+2,873
| +11% | +$288K | 1.07% | 36 |
|
|
2015
Q2 | $2.74M | Buy |
25,855
+464
| +2% | +$51.3K | 1.05% | 36 |
|
|
2015
Q1 | $2.9M | Hold |
25,391
| – | – | 1.09% | 36 |
|
|
2014
Q4 | $2.8M | Buy |
25,391
+155
| +0.6% | +$16.3K | 1.06% | 38 |
|
|
2014
Q3 | $2.46M | Sell |
25,236
-1,957
| -7% | -$192K | 0.98% | 41 |
|
|
2014
Q2 | $2.74M | Sell |
27,193
-1,030
| -4% | -$100K | 1.06% | 40 |
|
|
2014
Q1 | $2.59M | Sell |
28,223
-1,906
| -6% | -$176K | 1.02% | 38 |
|
|
2013
Q4 | $2.73M | Sell |
30,129
-2,549
| -8% | -$221K | 1.07% | 37 |
|
|
2013
Q3 | $2.61M | Sell |
32,678
-1,030
| -3% | -$81.1K | 1.09% | 38 |
|
|
2013
Q2 | $2.45M | Buy |
+33,708
| New | +$2.52M | 1.06% | 38 |
|
Other funds holding ZBH
VCM
VPM
Monarch Capital Management's ZBH Position: Q1 2026 in Review
Monarch Capital Management increased its Zimmer Biomet (ZBH) stake by 0.89% in Q1 2026, buying an estimated $30.3K and bringing the position to 37,388 shares worth $3.39M. The position accounts for 0.83% of the portfolio, ranked #40.
Monarch Capital Management first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.39M in Q4 2020. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Monarch Capital Management held 37,388 shares of Zimmer Biomet worth $3.39M as of Q1 2026.
- Monarch Capital Management bought 330 Zimmer Biomet shares in Q1 2026, an estimated $30.3K.
- Zimmer Biomet made up 0.83% of Monarch Capital Management's portfolio in Q1 2026, its #40 holding.
- Monarch Capital Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
- Monarch Capital Management's Zimmer Biomet position peaked at $6.39M in Q4 2020.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Monarch Capital Management's 13F filing for Q1 2026, filed 16 Apr 2026.